NA
ONC

NewEdge Advisors’s BeOne Medicines Ltd ONC Stock Holding History

NewEdge Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Sell
1,190
-675
-36% -$218K ﹤0.01% 2230
2025
Q4 		$566K Buy
1,865
+9
+0.5% +$2.95K ﹤0.01% 1880
2025
Q3 		$632K Buy
1,856
+304
+20% +$92.3K ﹤0.01% 1679
2025
Q2 		$376K Buy
1,552
+379
+32% +$92.9K ﹤0.01% 1874
2025
Q1 		$319K Buy
1,173
+1,172
+117,200% +$274K ﹤0.01% 1860
2024
Q4 		$109 Hold
1
– – ﹤0.01% 3776
2024
Q3 		$132 Hold
1
– – ﹤0.01% 3708
2024
Q2 		$84 Sell
1
-7
-88% -$1.08K ﹤0.01% 3695
2024
Q1 		$1.19K Sell
8
-97
-92% -$15.6K ﹤0.01% 3467
2023
Q4 		$18.9K Hold
105
– – ﹤0.01% 2585
2023
Q3 		$18.8K Sell
105
-395
-79% -$78.2K ﹤0.01% 2396
2023
Q2 		$89.1K Buy
500
+25
+5% +$5.76K ﹤0.01% 1887
2023
Q1 		$102K Sell
475
-80
-14% -$19.2K ﹤0.01% 1748
2022
Q4 		$6.71K Buy
+555
New +$102K ﹤0.01% 2492

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NewEdge Advisors's ONC Position: Q1 2026 in Review

NewEdge Advisors reduced its BeOne Medicines Ltd (ONC) stake by 36% in Q1 2026, selling an estimated $218K and leaving 1,190 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

NewEdge Advisors first reported a position in ONC in Q4 2022 and has held it in 14 quarters since. The position peaked at $632K in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • NewEdge Advisors held 1,190 shares of BeOne Medicines Ltd worth $353K as of Q1 2026.
  • NewEdge Advisors sold 675 BeOne Medicines Ltd shares in Q1 2026, an estimated $218K.
  • BeOne Medicines Ltd made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2230 holding.
  • NewEdge Advisors first reported a position in BeOne Medicines Ltd in Q4 2022 and has held it in 14 quarters since.
  • NewEdge Advisors's BeOne Medicines Ltd position peaked at $632K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.